Add this topic to your myFT Digest for news straight to your inbox
The UK has the potential to be a global leader in approving new industries but it must act quickly
Mounjaro has achieved 22.5 per cent loss of body weight in trials
Also in this week’s newsletter, the unintended consequences of Brexit on migration
Regulator authorises treatment for sickle cell disease and beta thalassaemia
The head of the UK’s medicines agency was dealing with the challenges of Brexit when the pandemic hit
MHRA chief in talks with watchdogs in Australia, Canada, Singapore and Switzerland to create partnership
Chancellor Jeremy Hunt vows to make Britain the ‘best place in Europe’ for tech companies to invest
Johnson government announces plan after similar moves in Scotland and Wales
UK medicines regulator approves antibody treatment sotrovimab for high-risk patients
First authorisation for antiviral drug that halves risk of hospitalisation or death
Filing offers boost for Covax vaccine programme which has agreed deal for 350m doses
MHRA set to make up to a quarter of its personnel redundant despite ‘phenomenal’ contribution in battle against Covid-19
Surge testing in Reading and Wokingham as Delta variant case numbers rise across UK
Watchdog concludes that single-dose jab meets the ‘expected standards’ of safety, quality and effectiveness
Regulator’s reaction questioned after emergence of blood clots linked to vaccine
European regulator also establishes link between jabs and rare blood clots
Clinical testing of jab with small group aged 6-17 suspended ahead of risk review from regulators
Regulators say shot is safe but UK records new clotting cases and growing number of countries restrict its use
Regulator says still no evidence of causal link and that benefits of the vaccine outweigh any risks
Decision makes approval possible in as little as two weeks after final data is received from manufacturers
Surveillance of AstraZeneca and Pfizer recipients in UK reports minor complaints but few severe reactions
Approach seeks to cut years off traditional licensing process for treatments
PM suggests Britain can give speedy approval to any jabs needed to deal with new variants of virus
Aim is to administer 2m doses of Oxford/AstraZeneca vaccine a week by end of January
Authorisation boosts hopes that millions more Britons can be inoculated in coming months
International Edition